Enesi Pharma has announced the appointment of Dr Steven Chatfield to its scientific advisory board.

Dr Chatfield is an internationally recognised vaccine and infectious disease expert and brings nearly 40 years’ experience in R&D, executive, board and advisory roles across a number of public and private healthcare organisations focused on this area. He has a proven track record of success through all stages of product discovery and development leading to registration, and has provided expert advice to industry, government and non-governmental organisations on vaccines, vaccination and public health issues, including biodefence.

David Hipkiss, CEO of Enesi Pharma, said: “We are very proud at Enesi to have been able to attract highly experienced and distinguished vaccine and vaccination experts to our SAB. The SAB provides importance guidance on key issues within the sector and where our ImplaVax platform could make the greatest impact.

"This has enabled us to prioritise and execute our strategic activities with considerable success to date in terms of the quality of our collaborations and our profile within the industry. Dr Chatfield is a fantastic addition, bringing unique and highly complementary experience and expertise to our SAB. We look forward to his contribution to our growing business.”